12 companies in Neurotechnology & BCI.
BrainsWay
Neurotechnology & BCI · Deep transcranial magnetic stimulation
Latest (Oct 26, 2026): BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives
Open profile →Nexalin Technology
Neurotechnology & BCI · Non-invasive brain stimulation devices
Latest (Sep 28, 2026): Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in Its Transition Toward Commercial Revenue Generation
Open profile →electroCore
Neurotechnology & BCI · Non-invasive vagus nerve stimulation
Latest (Sep 8, 2026): electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers
Open profile →Neuronetics
Neurotechnology & BCI · Transcranial magnetic stimulation for depression
Latest (Aug 11, 2026): Neuronetics Reports Second Quarter 2026 Financial and Operating Results
Open profile →ClearPoint Neuro
Neurotechnology & BCI · Navigation and delivery systems for procedures inside the brain
Latest (Oct 28, 2026): ClearPoint Neuro Reports Third Quarter 2026 Results
Open profile →NeuroOne Medical
Neurotechnology & BCI · Thin-film electrodes for brain recording and stimulation
Latest (Oct 5, 2026): NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order
Open profile →NeuroPace
Neurotechnology & BCI · Implanted responsive brain stimulation for epilepsy
Latest (Aug 11, 2026): NeuroPace Reports Second Quarter 2026 Financial Results and Raises 2026 Revenue Guidance
Open profile →Neuralink
Neurotechnology & BCI · Implanted brain-computer interface
Latest (Jun 12, 2025): Neuralink reports $649 million of equity sold in a private offering
Open profile →Precision Neuroscience
Neurotechnology & BCI · Thin-film brain-computer interface
Latest (Sep 28, 2026): Precision Neuroscience reports $250 million of securities sold in a private offering
Open profile →Science Corp.
Neurotechnology & BCI · Physical augmentation · Neural engineering, including a retinal prosthesis
Latest (Mar 6, 2026): Science Corp. reports $230 million of securities sold in a private offering
Open profile →Paradromics
Neurotechnology & BCI · High-data-rate brain-computer interface
No developments in the current window yet.
Open profile →Synchron
Neurotechnology & BCI · Brain-computer interface implanted through blood vessels
No developments in the current window yet.
Open profile →Coverage is not an offer to invest. Private ownership does not imply available shares. Sector labels are Sapien Frontier’s own coverage classification, not company claims.
Missing a company? Request future coverage. We add a company when its filings, offering notices or awards can be followed reliably. See what we cover and how often.